During the past decade, Heartland Cancer Research and Treatment Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Heartland Cancer Research and Treatment Center" are "Head and Neck Cancer" (1 trials), "Kidney Cancer" (1 trials), "Lung Cancer" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Heartland Cancer Research and Treatment Center" in a lesser frequency.

Most popular intervention types in "Heartland Cancer Research and Treatment Center" are "Drug" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "aldesleukin" (1 trials), "carboplatin" (1 trials), "cisplatin" (1 trials), "docetaxel" (1 trials) and "filgrastim" (1 trials). Other intervention names were less common.

The vast majority of trials in "Heartland Cancer Research and Treatment Center" are 3 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Heartland Cancer Research and Treatment Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Heartland Cancer Research and Treatment Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Heartland Cancer Research and Treatment Center, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".